HEAT Trial

Bifunctional antibody against EGFR and TGF Beta, alone and in combination with pembrolizumab for Head and neck cancer, NSCLC and anal cancer and cutaneous squamous cell cancer

Status:

Open

Trial Type:

Early Phase Trials for Multiple Cancer Types, Head and Neck Cancer, Lung Cancer, Melanoma and Skin Cancers

Contact:

Ari Birnbaum, MD

abirnbaum@brownhealth.org